Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Total Debt (2016 - 2024)

Historic Total Debt for Sanofi (SNY) over the last 17 years, with Q2 2025 value amounting to $23.2 billion.

  • Sanofi's Total Debt fell 83.34% to $23.2 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $23.2 billion, marking a year-over-year decrease of 83.34%. This contributed to the annual value of $17.1 billion for FY2024, which is 357.55% down from last year.
  • Latest data reveals that Sanofi reported Total Debt of $23.2 billion as of Q2 2025, which was down 83.34% from $17.1 billion recorded in Q4 2024.
  • In the past 5 years, Sanofi's Total Debt ranged from a high of $24.3 billion in Q2 2021 and a low of $17.1 billion during Q4 2024
  • Its 5-year average for Total Debt is $21.0 billion, with a median of $20.6 billion in 2023.
  • Per our database at Business Quant, Sanofi's Total Debt tumbled by 1647.04% in 2022 and then surged by 1353.95% in 2024.
  • Over the past 5 years, Sanofi's Total Debt (Quarter) stood at $23.2 billion in 2021, then dropped by 16.42% to $19.4 billion in 2022, then decreased by 9.17% to $17.6 billion in 2023, then decreased by 3.06% to $17.1 billion in 2024, then skyrocketed by 35.78% to $23.2 billion in 2025.
  • Its last three reported values are $23.2 billion in Q2 2025, $17.1 billion for Q4 2024, and $23.4 billion during Q2 2024.